Trumenba vaccine 0.5 ML Prefilled Syringe
- RxCUI
- 1593140
- RxNorm name
- Trumenba vaccine 0.5 ML Prefilled Syringe
- Display name
- Trumenba vaccine 0.5 ML Prefilled Syringe
- Full name
- Trumenba vaccine 0.5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125549 | Trumenba | Meningococcal Group B Vaccine | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| bcaf5f75-caaf-41fd-875b-5800310070d1 | Trumenba vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba] [SBD] · Trumenba (meningococcal group B vaccine) 0.5 ML Prefilled Syringe [SY] · Trumenba (Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 60 MCG / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 60 MCG) per 0.5 ML Prefilled Syringe [SY] | 4 | 23 | These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA ® (Meningococcal Group B Vaccine) Suspension for intramuscular injection Initial U.S. Approval: 2014 | 20260119 |